Physician profile
James E Zins
NPI 1588629851
$3,119.18
in general payments reported to CMS, 2019-2025
19 companies · $746 in 2025
The $746 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2021: $246 · 2022: $372 · 2023: $584 · 2024: $709 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,039.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $328.66 | 2019-2022 | |
| Aroa Biosurgery Incorporated | $305.30 | 2024-2025 | |
| Polynovo North America LLC | $298.17 | 2022-2025 | Novosorb Btm |
| Abbvie INC. | $284.47 | 2023-2025 | Botox |
| Avita Medical Americas, LLC | $278.06 | 2023-2025 | Recell |
| Integra Lifesciences Corporation | $262.78 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Allergan, INC. | $175.74 | 2021 | |
| W. L. Gore & Associates, INC. | $169.00 | 2023 | Gore Enform Preperitoneal Biomaterial |
| Baxter Healthcare | $144.71 | 2025 | Artiss |
| Smith+Nephew, INC. | $140.33 | 2019 | |
| Convatec INC. | $123.74 | 2023 | |
| Biotissue Holdings INC. | $121.92 | 2024 | |
| Mentor Worldwide LLC | $120.00 | 2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Horizon Therapeutics Plc | $113.72 | 2019 | |
| Dilon Technologies, INC. | $95.94 | 2024 | Hemoblast Bellows |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $87.91 | 2019 | |
| Amgen INC. | $36.01 | 2023-2024 | Otezla |
| Axogen | $16.47 | 2019 | |
| Sun Pharmaceutical Industries INC. | $16.25 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Zins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.